FDA Inspection
Laboratorios Liconsa SAULaboratorios Liconsa SAU – FDA Inspection, Jul 9, 2026
Record Details
This FDA Inspection record concerns Laboratorios Liconsa SAU, with an inspection on July 9, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 5cc57644-a02c-4548-80f8-5253527d3832
Inspection Facts
- Inspection number
- 1325076
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.170(b)Investigation of reserve sample deterioration
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Laboratorios Liconsa SAU
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | Not classified | Office of Inspections and Investigations | |
| April 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | Not classified | Office of Inspections and Investigations | |
| September 15, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Laboratorios Liconsa SAU
- FDA Inspection 1251910 - 2025-01-17
- FDA Inspection 1279060 - 2023-04-19
- FDA Inspection 1136711 - 2019-03-22
- FDA Inspection 1085151 - 2019-02-22
- FDA Inspection 1029229 - 2017-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.